melanocortin receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-07-24 and is reviewed periodically as new material appears.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
== Taxonomic distribution and evolutionary advantages == Action potentials are found throughout multicellular organisms, including plants, invertebrates such as insects, and vertebrates such as reptiles and mammals. Sponges seem to be the main phylum of multicellular eukaryotes that does not transmit action potentials, although some studies have suggested that these organisms have a form of electrical signaling, too. The resting potential, as well as the size and duration of the action potential, have not varied much with evolution, although the conduction velocity does vary dramatically with axonal diameter and myelination.
== Keratin removal == Keratin that is present in the hair, scales and in the epidermis of the skin is hydrolyzed in the presence of alkali (at pH values greater than 11.5). The disulfide bridges found in keratin protein are cleaved but can be reformed. Long periods of liming will result in hair removal. The main removal of keratin is performed during the unhairing operation. In traditional processing, liming and unhairing were indivisible and took place at the same time. During modern liming methods, and in particular the processing of sheepskins, the hair is removed first and then limed in a liming drum. In hair-save technology, the hides are unhaired first and then limed for a further 12–18 hours.
However, on April 9, Dana White, the president of UFC announced that this event was postponed to a future date Instead Casey is scheduled to face Mara Romero Borella on May 16, 2020 at UFC on ESPN: Overeem vs. Harris. She won the bout in the first round via submission through an armbar. This win earned her the Performance of the Night award. Casey faced Gillian Robertson on June 20, 2020 at UFC Fight Night: Blaydes vs. Volkov. She lost the fight via a rear-naked choke submission in round three. Casey was expected to face Priscila Cachoeira on October 31, 2020 at UFC Fight Night 181. However the bout was called off the day of the weigh-ins as Cachoeira had issues cutting weight. Casey faced JJ Aldrich on March 13, 2021 at UFC Fight Night 187. She lost the fight via split decision. Casey was expected to face Liana Jojua on August 21, 2021 at UFC on ESPN 29. However, Jojua was forced out of the fight due to visa issues. The matchup was rescheduled at UFC Fight Night 197 on November 13, 2021. At the weigh-ins, Jojua weighed in at 128.5 pounds, two and a half pounds over the flyweight non-title fight limit. The bout proceeded at a catchweight with Jojua fined 30% of her purse, which went to her opponent Casey. Casey won the bout via unanimous decision. Casey was scheduled to face Antonina Shevchenko on April 30, 2022 at UFC on ESPN 35. However, the bout was postponed to July 9, 2022 at UFC on ESPN 39 due Shevchenko injured her knee in training. Casey lost the fight via split decision. Casey was scheduled to face Jasmine Jasudavicius on February 25, 2023, at UFC Fight Night 220.
Methenamine, also known as 1,3,5,7-tetraazaadamantane, is a simple cyclic hydrocarbon with a cage-like structure and is similar in structure to adamantane (tricyclo[3.3.1.13,7]decane). It is specifically the analogue of adamantane in which the carbon atoms at the 1, 3, 4, and 7 positions have been replaced with nitrogen atoms. The drug is a white or colorless and odorless crystalline compound with a sweet, sour, and/or metallic taste. It is a hydrophilic compound with a predicted log P (XLogP3) of 0.3. Methenamine is usually provided medically as the hippuric acid or mandelic acid salt. Methenamine is the cation and hippuric acid or mandelic acid is the anion.
Sources: en.wikipedia.org
=== Pregnancy and lactation === Doxycycline is categorized by the FDA as a class D drug in pregnancy, meaning there is evidence of risk to the fetus but the benefits may outweigh the risks in certain situations. Doxycycline crosses into breast milk and is therefore a concern during breastfeeding. Other tetracycline antibiotics are contraindicated in pregnancy and up to eight years of age, due to the potential for disrupting bone and tooth development. The FDA includes a class warning for all tetracyclines about staining of teeth (typically yellow to brown discoloration) and decreased development of dental enamel in children exposed to tetracyclines in utero, during breastfeeding, or during early childhood (under eight years of age). However, the FDA has acknowledged that the actual risk of dental staining of primary teeth is undetermined for doxycycline specifically. The best available evidence indicates that doxycycline has little or no effect on hypoplasia (underdevelopment) of dental enamel or on staining of primary teeth (baby teeth). The US Centers for Disease Control and Prevention (CDC) recommends the use of doxycycline for treatment of Q fever and tick-borne rickettsial diseases in children of all ages, and some researchers advocate for its use in children with malaria as well.
=== Dendritic secretion === Supraoptic neurons have typically 1-3 large dendrites, most of which projecting ventrally to form a mat of process at the base of the nucleus, called the ventral glial lamina. The dendrites receive most of the synaptic terminals from afferent neurons that regulate the supraoptic neurons, but neuronal dendrites are often actively involved in information processing, rather than being simply passive receivers of information. The dendrites of supraoptic neurons contain large numbers of neurosecretory vesicles that contain oxytocin and vasopressin, and they can be released from the dendrites by exocytosis. The oxytocin and vasopressin that is released at the posterior pituitary gland enters the blood, and cannot re-enter the brain because the blood–brain barrier does not allow oxytocin and vasopressin through, but the oxytocin and vasopressin that is released from dendrites acts within the brain. Oxytocin neurons themselves express oxytocin receptors, and vasopressin neurons express vasopressin receptors, so dendritically released peptides "autoregulate" the supraoptic neurons. Francoise Moos and Phillipe Richard first showed that the autoregulatory action of oxytocin is important for the milk-ejection reflex. These peptides have relatively long half-lives in the brain (about 20 minutes in the CSF), and they are released in large amounts in the supraoptic nucleus, and so they are available to diffuse through the extracellular spaces of the brain to act at distant targets.
Saint Kitts and Nevis - The Scout Association of Saint Kitts and Nevis* Tonga - Tonga branch of The Scout Association* Tuvalu - Tuvalu Scout Association* Vanuatu - Vanuatu branch of The Scout Association* Served by Scouts Australia
Fe + CuSO4 → FeSO4 + Cu In high school and general chemistry education, copper sulfate is used as an electrolyte for galvanic cells, usually as a cathode solution. For example, in a zinc/copper cell, copper ion in copper sulfate solution absorbs electron from zinc and forms metallic copper.
=== Recurring === Isabella Rossellini as Franny Forst, Byron's estranged wife Nicola Peltz Beckham as Franny after the transformation John Carroll Lynch as FBI Supervisor Meyer Williams Patrick Luwis as Meyer after the transformation Rob Yang as Dr. Ray Lee, a scientist and the original developer of the "Beauty" drug who now works for Byron Ari Graynor as Dr. Diana Sterling, a roboticist and the creator of the "Deacons"
Sources: en.wikipedia.org
=== Mass spectrometry === Mass spectrometry can be used in the sequencing of MHC binding motifs, which can subsequently be used to predict T cell epitopes. The technique of peptide mass fingerprinting (PMF) can be used to check a peptide's mass spectrum against a database of protein digests which have already been documented. If the mass spectrum of the protein of interest as well as the database protein share a large amount of homology, it is likely that the protein of interest is contained within the sample.
== Research and development == In the 1970s, chemists at Dr. Karl Thomae GmbH, a subsidiary of Boehringer-Ingelheim in Germany, synthesized a variety of enol carboxamides with the aim of obtaining active ingredients with anti-inflammatory or antithrombotic properties. A compound belonging to the oxicams (UH-AC 62, meloxicam) stood out, exhibiting antiinflammatory activity in the pharmacological adjuvant arthritis model, but only low antithrombotic efficacy as measured by platelet aggregation. Dr. Karl Thomae GmbH filed the German basic patent DE2756113 (1979) and Boehringer Ingelheim US patent 4,233,299 (1980) and patents in many other countries.
Military advice from the era also suggests plundering seized enemy storehouses and granaries to provision an army. The Aztecs timed their war seasons to begin just after the harvest. Armies would be equipped with foodstuffs such as toasted tortillas, beans, chilies, dried meats such as venison, turkey, and peccary, and cacao paste. Armies on campaign brought along young cadet soldiers who acted as porters, carrying up to 50 pounds (23 kg) of supplies and equipment each. Soldiers heading off on campaign would receive contributions from their families and communities. While on the move, armies collected food from tributary cities. Messengers were sent ahead of an approaching army to demand stockpiled tribute. Refusal to contribute was seen as an act of rebellion. The Inca Empire ensured that its armies could frequently be resupplied while on the move. Inca armies moved along an extensive road system dotted with waystations that ensured troops did not have to march more than 20 kilometers without being resupplied. Their supplies were carried by llamas as well as porters. Food and weapons were stockpiled in storehouses called qullqa that dotted the countryside, which armies could draw upon as they moved. The Incas strictly prohibited their soldiers from looting local communities, punishing such offenses with execution. The food eaten by soldiers was largely the same as that consumed by the civilian population in daily life, although they probably ate dehydrated food more frequently. Therefore, staples would have included corn, potatoes, and quinoa.
Founded in 1949 by Sally Everett, the chain began its expansion under Sally's son Donald Everett Sr. in 1966, and started franchising restaurants in 1979. As of November 2020, there are 85 Runza restaurants operating: 80 in Nebraska, two in Iowa, two in Colorado, and one in Kansas. The restaurant chain is still owned by the Everett family, and Sally's grandson Donald Everett Jr. serves as President. In addition to the namesake sandwich, the chain serves chili and cinnamon rolls (another Midwest dish), as well as other fast food staples like hamburgers, french fries and onion rings. The chain attempted to expand beyond the region in 1989. Executives tried to open a restaurant in the Latvian republic of the Soviet Union, going as far as shipping two hundred frozen Runza sandwiches to the Soviet Ministry of Agriculture as a part of its negotiations. The deal fell apart after Latvia was invaded by the Soviet government in an attempt to keep it in the Union. Stores did open in the Las Vegas Strip at the Fashion Show Mall's food court and a mall food court in Moline, Illinois but both failed to gain traction and closed within a few years.
== History == Dihexa was developed by Joseph Harding and his team at Washington State University. Later developments were done by M3 Biotechnology, a company founded to commercialize dihexa. Fosgonimeton, a phosphate pro-drug of dihexa is currently in clinical trials for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.